Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

News SummaryMost relevantAll newsSector news 

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

11/14/2008 | 04:15pm US/Eastern

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.

React to this article
11/19 PRESSURE BIOSCIENCES INC : SeeThruEquity Issues Update on Pressure BioSciences (..
11/17 PRESSURE BIOSCIENCES : Closes Additional $745,000 of $5 Million PIPE; Funding Re..
11/13 PRESSURE BIOSCIENCES INC : Strong Revenue Growth in the $6 Billion Biological Sa..
11/05 PRESSURE BIOSCIENCES INC : SeeThruEquity Issues Update on Pressure BioSciences (..
10/20 PRESSURE BIOSCIENCES INC : New Tech Partnership Aims for Faster Rape Kit Process..
10/08 PRESSURE BIOSCIENCES : Closes Additional $1,100,000 of $5 Million PIPE; Total Fu..
09/29 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
09/17 PRESSURE BIOSCIENCES : StockNewsNow.com Publishes Q3 2015 Review SNNLive Video I..
08/18 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
08/14 PRESSURE BIOSCIENCES : Management's Discussion and Analysis of Financial Conditi..